Pain in nursing home residents: Management strategies

Drugs and Aging

Volumn 18, Issue 1, 2001, Pages 13-29

  Weiner, Debra K ^a   Hanlon, Joseph T ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTICONVULSIVE AGENT; BACLOFEN; CALCITONIN; CAPSAICIN; DESIPRAMINE; DEXTROMETHORPHAN; IBUPROFEN; LEVODOPA; LIDOCAINE; MEXILETINE; NAPROXEN; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; NORTRIPTYLINE; PARACETAMOL; ROFECOXIB; SALSALATE; SULINDAC; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT;

AGED; COGNITIVE THERAPY; COMORBIDITY; DEMENTIA; DISEASE COURSE; DISEASE EXACERBATION; DRUG ABSORPTION; DRUG CLEARANCE; DRUG DEPENDENCE; DRUG DOSE; DRUG INDICATION; DRUG METABOLISM; DRUG TOLERABILITY; DRUG TOLERANCE; HUMAN; LIVER TOXICITY; NURSING HOME; PAIN; PAIN ASSESSMENT; PHYSIOTHERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; RATING SCALE; REVIEW; SIDE EFFECT; TRANSCUTANEOUS NERVE STIMULATION;

AGED; ANALGESICS, OPIOID; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DRUG ADMINISTRATION SCHEDULE; GERIATRICS; HALF-LIFE; HUMANS; NURSING HOMES; PAIN; PAIN MEASUREMENT; PREVALENCE;

EID: 0035117357     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-200118010-00002     Document Type: Review

References (156)

1. A survey of chronic pain in an elderly population
2. Pain in the nursing home
3. The problem of pain and its detection among geriatric nursing home residents
4. Assessment of pain in the elderly
5. Pain in nursing home residents: An exploration of prevalence, staff perspectives and practical aspects of measurement
6. Predictors of pain self-report in nursing home residents
7. The relationships among anxiety, depression, and pain in a geriatric institutionalized sample
8. Chronic pain and depression: Does the evidence support a relationship?
9. Association of pain and physical dependency with depression in physically ill middle-aged and elderly
10. Chronic musculoskeletal pain and depressive symptoms in the general populatiun: An analysis of the 1st National Health and Nutrition Examination Survey data
11. Pain, activity restriction, and symptoms of depression among community-residing adults
12. Pain and depression in the nursing home: Corroborating results
13. Evaluating and managing chronic pain
14. Cognitive impairment in musculoskeletal pain patients
15. Attention and somatic awareness in chronic pain
16. Prevalence and functional correlates of low back pain in the elderly: The Iowa 65+ Rural Health Study
17. Factors that disturb sleep in nursing home residents
18. Daily diary and ambulatory activity monitoring of sleep in patients with insomnia associated with chronic musculoskeletal pain
19. Empirical evidence of the association between the presence of musculoskeletal pain and physical disability in community-dwelling senior citizens
20. Defining arthritis and measuring functional status in elders: Methodological issues in the study of disease and physical disability
21. Disaggregating pain and its effect on physical functional limitations
22. The role of pain in the last year of life in older persons
23. Investigating the relationship between pain and discomfort and quality of life, using the WHOQOL
24. Lifetime use of nursing home care
25. Management of pain in elderly patients with cancer
26. Pain and its treatment in outpatients with metastatic cancer
27. Correlates and management of nonmalignant pain in the nursing home
28. Treatment of pain in cognitively impaired compared with cognitively intact older patients with hip-fracture
29. Undertreatment of medical inpatients with narcotic analgesics
30. The knowledge, attitudes, and experience of medical personnel treating pain in the terminally ill
31. The pharmacological management of the elderly patient with terminal cancer pain
32. ExpLicit criteria for determining potentially inappropriate medication use by the elderly. An update
33. Inappropriate use of nonpsychotropic medications in the nursing home
34. Drug use in the nursing home
35. The prevalence and characteristics of fibromyalgia in the general population
36. Fibromyalgia syndrome among the elderly-comparison with younger patients
37. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia-report of the multicenter criteria committee
38. Fear-avoidance and its consequences in chronic musculoskeletal pain: A state of the art
39. Attitudinal barriers to effective pain management in the nursing home
40. The impact of dementia on the pain experience
41. Studies of anxiety associated with anticipation of pain: Effects of morphine
42. Existential consequences of unrelieved cancer pain
43. A study of the natural history of back pain-part I: Development of a reliable and sensitive measure of disability in low-back pain
44. The McGill pain questionnaire: Major properties and scoring methods
45. Evaluating persistant pain in long term care residents: What role for pain maps?
46. Pain drawings and sickle cell disease pain
47. The pain drawing as an aid to the psychologic evaluation of patients with low-back pain
48. Site of pain: Relationship to measures of pain description, behavior and personality
49. Pain extent: Relations with psychological state, pain severity, pain history and disability
50. A rating system for use with patient pain drawings
51. Evaluation of the faces pain scale for use with the elderly
52. Visual analogue scales for pain assessment in Alzheimer's disease
53. Pain measurement in elders with chronic low back pain: Traditional and alternative approaches
54. The tragedy of dementia: Clinically assessing pain in the confused nonverbal elderly
55. Assessment of discomfort in advanced Alzheimer patients
56. The assessment of pain in children and adolescents
57. Efficacy of multidisciplinary pain treatment centers: A meta-analytic review
58. Studies of illness in the aged - The index of ADL: A standardized measure of biological and psychosocial function
59. Development and validation of a geriatric depression screening scale: A preliminary report
60. Medical correlates of agitation in nursing home residents
61. Cognitive status and postoperative pain: Older adults
62. Chronic pain and attention: A cognitive approach
63. Chronic pain and distraction: An experimental investigation into the role of sustained and shifting attention in the processing of chronic persistent pain
64. Cognitive performance, mood and experimental pain before and during morphine-induced analgesia in patients with chronic non-malignant pain
65. Mini-mental state: A practical method for grading the cognitive state of patients for the clinician
66. The impact of postoperative pain on the development of postoperative delirium
67. Cognitive-behavioral pain management for elderly nursing home residents
68. Pain mechanisms: A new theory
69. Diets, dietary supplements, and nutritional therapies in rheumatic diseases
70. Hope helps: Placebos and alternative medicine in rheumatology
71. Why I would recommend complementary or alternative therapies: A physician's perspective
72. Why I would not recommend complementary or alternative therapies: A physician's perspective
73. Why I would want to use complementary and alternative therapy: A patient's perspective
74. Talking with patients about alternative and complementary medicine
75. Systematic review of randomized clinical trials of complementary/alternative therapies in the treatment of tension-type and cervicogenic headache
76. Complemenatry medicine treatments for fibromyalgia syndrome
77. The third therapeutic revolution: Behavioral medicine
78. Therapeutic touch: A healing modality
79. The evidence for acupuncture as a treatment for rheumatologic conditions
80. A randomized trial comparing aerobic exercise and resistance exercise with a health education program in older adults with knee osteoarthritis. The Fitness Arthritis and Seniors Trial (FAST)
81. Home exercise in rheumatoid arthritis functional class II: Goal setting versus pain attention
82. Management of cancer pain
83. Acetaminophen kinetics in the elderly
84. The association of age and frailty with paracetamol conjugation in man
85. Comparison of an anti-inflammatory close of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee
86. Association of acetaminophen hepatotoxicity with fasting and ethanol use
87. Concerns with chronic analgesic therapy in elderly patients
88. Are selective COX-2 inhihitors nephrotoxic?
89. The cyclo-oxygenase-2 inhibitors: Safety and effectiveness
90. The pharmacokinetics of non-steroidal anti-inflammatory drugs in the elderly
91. NSAIDs and faecal blood loss in elderly patients with osteoarthritis: Is plasma half-life relevant?
92. Acute and chronic effects of nonsteroidal antiinflammatory drugs on glomerular filtration rate in elderly patients
93. Risk of serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs: A meta-analysis
94. Medical progress: Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs
95. Are selective COX-2 inhibitors nephrotoxic?
96. Drugs for rheumatoid arthritis
97. Relation of prescription nonsteroidal anti-inflammatory drug use and cognitive function among community dwelling elderly
98. Drug-induced cognition disorders in the elderly-incidence, prevention, and management
99. Concurrent use of nonsteroidal anti-inflammatory drugs and oral anticoagulants places elderly persons at high risk for hemorrhagic peptic ulcer disease
100. Non-steroidal anti-inflammatory drugs
101. Defining inappropriate practices in prescribing for elderly people: A national consensus panel
102. Opioid analgesic drugs in the elderly
103. A comparative evaluation of marketed analgesic drugs
104. ACP-ASIM End of Life Care Consensus Panel. Management of pain and spinal cord compression in patients with advanced cancer
105. Efficacy of oxycodone in neuropathic pain: A randomized controlled trial in post-herpetic neuralgia
106. Influence of age on pain relief from analgesics
107. Decreased fentanyl and alfentanil dose requirements with age: A simultaneous pharmacokinetic and pharmacodynamic evaluation
108. Age and morphine analgesia in cancer patients with postoperative pain
109. Sublingual absorption of selected opioid analgesics
110. Kinetics of intravenous and intramuscular morphine
111. Narcotics in the elderly
112. Age-related morphine kinetics
113. Age and the pharmacokinetics of morphine
114. The effect of aging on plasma pethidine concentration
115. Comparative disposition of pethidine and norpethidine in the old and young patients
116. Effects of age on meperidine disposition
117. Comparison of renal excretion of meperidine and its metabolites in old and young patients
118. Transdermal fentanyl disposition in elderly subjects
119. Perioperative pharmacokinetics of transdermal fentanyl in elderly and young adult patients
120. CNS drug-related falls hability in community dwelling elderly
121. Opioid analgesics and the risk of hip fracture in the elderly: Codeine and propoxyphene
122. Drug-related falls in the elderly
123. Addiction rare in patients treated with narcotics
124. The psychomimetic side effects of pentazocine
125. Nortriptyline versus amitriptyline in postherpetic neuralgia: A randomized trial
126. A guide to the understanding and use of tricyclic antidepressants in the overall management of fibromyalgia and other chronic pain syndromes
127. Cardiovascular effects of antidepressant drugs: Updated
128. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy
129. The efficacy of selective serotonin reuptake inhibitors for the management of chronic pain
130. A randomized, couble-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia
131. The treatment of trigeminal neuralgia (tic douloureux)
132. Epidemiology and drug treatment of epilepsy in elderly people
133. Gabapentin for the treatment of postherpetic neuralgia: A randomized controlled trial
134. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: A randomized controlled trial
135. Polymyalgia rheumatica and temporal arteritis
136. Giant cell arteritis: Signs and symptoms
137. Topical capsaicin: A review of its pharmacological properties and therapeutic potential in postherpetic neuralgia, diabetic neuropathy and osteoarthritis
138. Topical capsaicin as an adjuvant analgesic
139. Tramadol - A new analgesic
140. Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy
141. Tramadol
142. A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes
143. Treatment of postherpetic neuralgia
144. Analgesic drugs for neuropathic and sympathetically maintained pain
145. Optimal treatment of phantom limb pain in the elderly
146. Herpes zoster and postherpetic neuralgia. Optimal treatment
147. Peripheral diabetic neuropathy: Concurrent recommendations and future prospects for its prevention and management
148. Chronic neuropathic pain and its control by drugs
149. Fibromyalgia syndrome a decade later. What have we learned?
150. Management of fibromyalgia
151. Do antioxidant micronutrients protect against the development and progression of knee osteoarthritis?
152. Therapeutic equivalence of alendronate 70mg once-weekly and alendronate 10mg daily in the treatmen of osteoporosis
153. Managing acute osteoporotic vertebral fractures with calcitonin
154. The management of chronic pain in older persons